FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula I wherein AA is selected from the group consisting of L-Ala, L-Val, L-Trp, L-Tyr, L-Pro, L-Phe, Gly, L-Ser, L-Ile, L-Thr, L-Lys, L-Leu, L-Gln, L-Asn, L-Asp and L-Glu, simultaneously possessing triple activity in the form of thrombolysis, antithrombosis and free radical scavenging, as well as to the method for preparing the composition.
.
EFFECT: compounds are intended for the treatment of stroke or cerebral infarction.
7 cl, 9 dwg, 13 tbl, 68 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL COMPOUND WITH EFFECTS OF THROMBOLYSIS, ACCEPTING FREE RADICALS AND DIRECTED ACTION ON THROMBUS, AS WELL AS METHOD FOR PRODUCTION AND USE THEREOF | 2013 |
|
RU2604193C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING THROMBOLYTIC PEPTIDE-TETRAHYDROISOQUINOLINE CONJUGATE | 2020 |
|
RU2825937C1 |
| NOVEL INDOLE AND PYRROLE COMPOUNDS, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2014 |
|
RU2693404C2 |
| ANTIBODY AND DRUG CONJUGATES (ADC) AND ANTIBODY AND PRODRUG CONJUGATES (APDC) CONTAINING ENZYMATICALLY CLEAVABLE GROUPS | 2016 |
|
RU2751512C2 |
| NOVEL ISOINDOLINE OR ISOQUINOLINE COMPOUNDS, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2014 |
|
RU2689305C2 |
| ANTIBODIES TO B7-H3 AND CONJUGATES OF ANTIBODY AND DRUG | 2017 |
|
RU2764651C2 |
| NOVEL PYRROLE COMPOUNDS, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2607788C2 |
| SPECIFIC PLADIENOLIDE COMPOUNDS AND METHODS OF THEIR USE | 2019 |
|
RU2813597C2 |
| N1/N2-LACTAM ACETYL-CoA-CARBOXYLASE INHIBITORS | 2011 |
|
RU2540337C2 |
| RESORCINOL DERIVATIVE AS HSP90 INHIBITOR | 2016 |
|
RU2697703C2 |
